Around the Web — 2.2.23
FDA yesterday approved daprodustat tablets (Jesduvroq, GlaxoSmithKline) as the first oral treatment for anemia caused by chronic kidney disease for adults who have been receiving
Michael Posey
February 2, 2023
FDA yesterday approved daprodustat tablets (Jesduvroq, GlaxoSmithKline) as the first oral treatment for anemia caused by chronic kidney disease for adults who have been receiving
FDA on Friday issued an immediately-in-effect guidance on compounding certain ibuprofen products to improve the supply of ibuprofen oral suspension products amid record high demand. The guidance
The 37 new chemical/biological entities approved by FDA during 2022 are discussed in an FDA Voices article published this week. Written by Patrizia Cavazzoni, director
On Friday, the FDA granted accelerated approval to lecanemab-irmb (Leqembi, Eisai R&D Management Co.) for treating Alzheimer’s disease in patients with mild cognitive impairment or
FDA last week approved ublituximab-xiiy (Briumvi, TG Therapeutics) for treating adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease,
The FDA is exploring ways it can regulate CBD in foods and supplements, the Wall Street Journal reports. “The FDA has approved a drug named
FDA last week approved lenacapavir (Sunlenca, Gilead), the first of a new capsid inhibitor class, for combination therapy in heavily treatment-experienced adults with multidrug-resistant (MDR)
FDA yesterday approved a new indication for tocilizumab (Actemra, Genentech) injection for the treatment of hospitalized adult patients with COVID-19 who are receiving systemic corticosteroids
FDA this week granted accelerated approval to adagrasib (Krazati, Mirati Therapeutics), a RAS GTPase family inhibitor, for adult patients with KRASG12C-mutated locally advanced or metastatic
In the 2 years since COVID-19 vaccines entered clinical testing, administration of 665 million doses to Americans has averted nearly 120 million infections, 18.6 million